This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Aetiology

Authoring team

The aetiology of multiple myeloma is unknown (1).

The origin of the malignant clone in myeloma is the subject of debate but multistep genetic and microenvironmental changes appears to be responsible for the differentiation into malignant plasma cells (2).

The proliferating cells in myeloma occur principally in the bone marrow causing diffuse infiltration and localised solid tumours.

The myeloma cells secrete an osteoclast stimulating factor that leads to marked bone erosion.

The main sites for myeloma involvement are the proximal long bones, the pelvis, the thoracic cage, the vertebral column and the skull.

Risk factors thought to be responsible for multiple myeloma include:

  • increasing age
  • male gender
  • Afro-Caribbean ethnic groups
  • positive family history - an increased risk of developing multiple myeloma was observed in 1st-degree relatives of patients with multiple myeloma
  • obesity - an elevated relative risk have been reported in a few epidemiologic studies
  • diet - low fish and green vegetable consumption
  • other risk factors thought to be associated with multiple myeloma but lack consistent data are - hair dye use, wood dust or wood exposures, chronic immune stimulation conditions and/or vaccinations for such conditions (3)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.